CDC Influenza Division Key Points November 7, 2014

Size: px
Start display at page:

Download "CDC Influenza Division Key Points November 7, 2014"

Transcription

1 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates that seasnal influenza activity remains lw, thugh there are early signs that activity is increasing. Flu activity is expected t increase in the cming weeks. Surveillance shws that mst circulating viruses s far this seasn are influenza A (H3N2) and influenza B viruses. There is very little circulatin f influenza A (H1N1) s far. (See the FluView Activity Update belw.) While mst f the viruses analyzed in recent mnths are like the vaccine viruses, there are sme influenza A (H3N2) viruses that are antigenically drifted frm the H3N2 virus cmpnent used in this seasn s vaccine. (See sectin "H3N2 Match and Vaccinatin.") CDC recmmends a three-prnged apprach t fighting flu: First, take time t get a flu vaccine. Secnd, take everyday preventive actins like cvering cughs and sneezes, staying away frm sick peple and washing yur hands ften t help stp the spread f respiratry viruses like flu, respiratry syncytial virus (RSV), rhinvirus and entervirus D68. Third, antivirals shuld be used as recmmended as a secnd line f defense t treat flu illness. Annual flu vaccinatin is the first and mst imprtant step in prtecting against flu and its ptentially serius cmplicatins. Getting vaccinated befre influenza activity begins helps prtect yu nce the flu seasn starts in yur cmmunity. It takes abut tw weeks after vaccinatin fr the bdy s immune system t fully respnd and fr yu t be prtected. Peple wh have nt been vaccinated yet this seasn shuld get vaccinated nw. 1

2 Patients shuld get immunized with whatever vaccine is immediately available and indicated. Influenza vaccinatin shuld nt be delayed t prcure a specific vaccine preparatin. The HealthMap Vaccine Finder can be used t lcate vaccine. Yu need this seasn s influenza vaccine fr ptimal prtectin against the flu. (Immunity frm vaccinatins declines ver time.) While hw well the flu vaccine wrks can vary, vaccinatin has been shwn t reduce flu illnesses, dctrs' visits, and missed wrk and schl due t influenza, as well as prevent flu-related hspitalizatins and deaths. Flu vaccinatin can help prtect peple wh are at greater risk f getting seriusly ill frm flu, like lder adults, peple with chrnic health cnditins and yung children (especially infants yunger than 6 mnths ld wh are t yung t get vaccinated). Seven influenza vaccine manufacturers have prjected that as many as 151 millin t 156 millin dses f influenza vaccine will be available fr use in the United States during the influenza seasn. As f Octber 31, millin dses f influenza vaccine had been distributed in the United States, which means that mre vaccine has been distributed than at this time last seasn. There are several flu vaccine ptins available fr the flu seasn. Flu shts made t prtect against three different flu viruses (called trivalent vaccines) are available this seasn. There als are flu shts and nasal spray vaccines made t prtect against fur different flu viruses (called quadrivalent vaccines). Abut half f the ttal influenza vaccine supply will be quadrivalent, while the ther half will be trivalent. There is sme evidence t suggest that the nasal spray vaccine may nt prtect children against H1N1 viruses during the seasn. (See the sectin LAIV Effectiveness and Vaccinatin f Children belw.) CDC recmmends that parents shuld get their children immunized with whatever vaccine is immediately available and indicated. Sme children 6 mnths thrugh 8 years f age getting vaccinated fr this first time will require tw dses f flu vaccine. The secnd dse shuld be given at least 28 days after the first dse. Yur child s dctr r ther health care prfessinal can tell yu whether tw dses are recmmended fr yur child.

3 And remember that influenza antiviral drugs are a secnd line f defense t treat flu illness. Antiviral drugs can treat flu illness and prevent serius flu cmplicatins. These drugs wrk best when started sn after influenza symptms begin (within 2 days), but persns with high-risk cnditins can benefit even when antiviral treatment is started after the first tw days f illness. A dctr r health care prfessinal can determine if a patient needs flu antiviral drugs. Influenza vaccinatin and rapid antiviral treatment are especially imprtant fr peple at high risk fr flu cmplicatins. Peple at high risk fr serius flu cmplicatins include: peple with underlying chrnic medical cnditins such as asthma, diabetes, heart disease, r neurlgical cnditins; pregnant wmen; thse yunger than 5 years r lder than 65 years f age; r anyne with a weakened immune system. A full list f high risk factrs is available at As always, peple wh are at high risk fr influenza cmplicatins shuld see a health care prfessinal prmptly if they get flu symptms, even if they have been vaccinated this seasn. Mre infrmatin abut everyday preventive actins that help fight flu is available at Flu symptms include fever, cugh, sre thrat, runny r stuffy nse, muscle r bdy aches, headache, chills and fatigue. FluView Activity Update Accrding t this week s FluView reprt, verall seasnal flu activity remains lw acrss the United States. Increases in flu activity are expected in the cming weeks. Belw is a summary f the key flu indicatrs fr the week ending Nvember 1, 2014: Fr the week ending Nvember 1, the prprtin f peple seeing their health care prvider fr influenza-like illness (ILI) was belw the natinal baseline. All 10 U.S. regins reprted ILI activity belw regin-specific baseline levels. Puert Ric experienced high ILI activity. One state (Luisiana) experienced lw ILI activity. New Yrk City and 49 states experienced

4 minimal ILI activity. The District f Clumbia did nt have sufficient data t calculate an activity level. ILI activity data indicate the amunt f flulike illness that is ccurring in each state. Guam reprted widespread gegraphic influenza activity. Tw states (Alaska and Flrida) reprted reginal influenza activity. Puert Ric and three states (Cnnecticut, Oregn, and Texas) reprted lcal activity. The District f Clumbia and 40 states reprted spradic influenza activity. Five states (Idah, Missuri, New Hampshire, Nrth Carlina, and Rhde Island) reprted n influenza activity. The U.S. Virgin Islands did nt reprt. Gegraphic spread data shw hw many areas within a state r territry are seeing flu activity. Data regarding influenza-assciated hspitalizatins fr the influenza seasn is nt yet available fr this seasn. The prprtin f deaths attributed t pneumnia and influenza (P&I) based n the 122 Cities Mrtality Reprting System is belw the epidemic threshld. N influenza-assciated pediatric deaths were reprted t CDC during the week ending Nvember 1. One influenza-assciated pediatric death has been reprted fr the seasn and ccurred during the week ending Octber 4, Natinally, the percentage f respiratry specimens testing psitive fr influenza viruses in the United States during the week ending Nvember 1 was 6.0%. Fr the mst recent three weeks, the reginal percentage f respiratry specimens testing psitive fr influenza viruses ranged frm 1.2% t 9.3%. Influenza A (H3N2), 2009 influenza A (H1N1), and influenza B viruses h have been identified mst cmmnly in the United States this seasn. Very few H1N1 viruses have been reprted. During the week ending Nvember 1, 394 (78.2%) f the 504 influenza-psitive tests reprted t CDC were influenza A viruses and 110 (21.8%) were influenza B viruses. Of the 121 influenza A viruses that were subtyped, 99.2% were H3 viruses and 0.8% were 2009 H1N1 viruses. CDC has antigenically characterized 10 influenza A (H3N2) viruses cllected in the United States since Octber 1, Seven (70%) f the 10 influenza A (H3N2) viruses tested have been characterized as A/Texas/50/2012-like. This is the influenza A (H3N2) cmpnent f the Nrthern Hemisphere influenza vaccine. Three (30%) H3N2 viruses were antigenically

5 similar t A/Switzerland/ /2013, the H3N2 virus selected fr the 2015 Suthern Hemisphere influenza vaccine. Since Octber 1, 2014, CDC has tested six influenza A (H3N2) fr resistance t neuraminidase inhibitrs (seltamivir and zanamivir). All six influenza A (H3N2) viruses shwed susceptibility t bth seltamivir and zanamivir. The neuraminidase inhibitrs seltamivir and zanamivir are currently the nly recmmended influenza antiviral drugs. As in recent past seasns, high levels f resistance t the adamantanes (amantadine and rimantadine) cntinue t persist amng 2009 influenza A (H1N1) and A (H3N2) viruses. Adamantanes are nt effective against influenza B viruses. FluView is available and past issues are archived n the CDC website. Nte: Delays in reprting may mean that data changes ver time. The mst up t date data fr all weeks during the seasn can be fund n the current FluView. LAIV Effectiveness Last Seasn and Vaccinatin f Children This Seasn Since 2008, ACIP and CDC have recmmended that all children 6 mnths and lder (with rare exceptins) receive influenza vaccine annually, using any licensed age-apprpriate vaccine. During the summer f 2014, ACIP and CDC recmmended that beginning during the influenza seasn, live attenuated influenza vaccine (LAIV, r the "nasal spray vaccine") shuld be used fr healthy children 2 thrugh 8 years f age when immediately available and when there are n cntraindicatins r precautins against getting that vaccine. This decisin was based n previus data shwing that LAIV ffered superir prtectin against influenza virus infectin cmpared t IIV in yung children. Hwever recently available CDC analyses shwed that there was n measurable effectiveness fr LAIV against influenza A (H1N1) amng children enrlled in the study last seasn. There were nt enugh cases f infectin with H3N2 r B viruses t calculate vaccine effectiveness against thse viruses in children last seasn. The reasns behind the lack f effectiveness against H1N1infectins fr LAIV during the seasn are nt fully understd.

6 It is pssible that results may be specific t the H1N1 cmpnent f LAIV. Influenza H1N1 viruses predminated during the seasn fr the first time since their emergence in 2009 when they caused a pandemic. It als is pssible thugh less likely that there is an unidentified issue with the study methds r analysis plan fr measuring LAIV vaccine effectiveness. The seasn LAIV VE estimates against H1N1 fr children suggest that LAIV may nt prtect against H1N1 viruses during the seasn because the same H1N1 vaccine virus frm the vaccine is included in the vaccine. Hwever, the nasal spray vaccine cntinues t be a recmmended ptin fr vaccinatin because: All LAIV is designed t prtect against fur different influenza viruses: Influenza A (H1N1), A (H3N2) and tw influenza B viruses. Surveillance shws that there is substantially mre circulatin f influenza A (H3N2) and B viruses and very little circulating H1N1 s far; LAIV has been shwn t ffer gd prtectin against influenza A (H3N2) and influenza B viruses in the past; LAIV may ffer better prtectin than IIV against antigenically drifted viruses that may circulate this seasn; and Vaccine prviders have received their vaccine fr the seasn and have likely administered a gd prprtin f it. Peple wh have nt been vaccinated yet this seasn shuld get vaccinated nw. Parents shuld seek t get their children immunized with whatever vaccine is immediately available and indicated. Influenza vaccinatin shuld nt be delayed t prcure a specific vaccine preparatin. The HealthMap Vaccine Finder can be used t lcate vaccine. Children needing ne dse f vaccine this seasn wh gt the nasal spray vaccine are cnsidered fully vaccinated and d nt need t be revaccinated. Children needing tw dses f vaccine this seasn wh have nly gtten ne dse can get either the nasal spray vaccine r the flu sht as their secnd dse, whatever is immediately available.

7 See the CDC statement, CDC Statement n LAIV Effectiveness and Vaccinatin f Children, at: H3N2 Match and Vaccinatin Surveillance f influenza viruses shws that sme f the influenza A (H3N2) viruses cllected dmestically and internatinally in recent mnths are antigenically different ( drifted ) frm the H3N2 vaccine cmpnent. An Octber 3 Mrbidity and Mrtality Weekly Reprt "Influenza Update" reprted that f 141 influenza A (H3N2) viruses cllected glbally between May 18-September 20, 2014 and characterized by CDC, 69 (49%) were antigenically similar t A/Texas/50/2012, the influenza A (H3N2) cmpnent f the influenza vaccine fr the Nrthern Hemisphere. Only 10 A (H3N2) viruses cllected in the United States since Octber 1, 2014 have been characterized s far this seasn. Seven f these (70%) are like the A (H3N2) vaccine virus, 3 (30%) have been characterized as A/Switzerland/ /2013, an antigenic variant virus which has been selected fr the 2015 Suthern Hemisphere influenza vaccine. A/Switzerland viruses were first cllected in March 2014, after the vaccine viruses fr the Nrthern Hemisphere vaccine had already been made in February. Initially, A/Switzerland viruses appeared nly spradically, but became mre cmmn ver the summer. Hw well the vaccine wrks depends in part n the match between vaccine viruses and circulating flu viruses. If the viruses are well-matched, vaccine effectiveness tends t be higher. If they are nt well-matched, vaccine effectiveness can be lwer. If drifted influenza A (H3N2) viruses circulate bradly in the United States this seasn, this culd translate int reduced vaccine effectiveness against circulating H3N2 viruses. Even when drifted viruses are fund t be circulating, CDC cntinues t recmmend influenza vaccinatin because: Studies have shwn evidence that seasnal influenza vaccinatin can smetimes induce antibdies and/r T cells capable f crss-reacting with antigenically distinct viruses. This is called crss-prtectin. While vaccine effectiveness may be reduced, the vaccine can still ffer prtectin.

8 Mre than ne type r subtype f influenza usually circulates during a single seasn and flu vaccines prtect against three r fur different influenza viruses, depending n which vaccine is given. Flu vaccinatin cntinues t ffer the best prtectin against influenza infectin, even when there are sme antigenically drifted viruses circulating in the cmmunity. Influenza antiviral treatment is an imprtant secnd line f defense t treat flu illness in the event f infectin. Visit the CDC website fr infrmatin abut hw antiviral medicatins can be used t prevent r treat influenza when influenza activity is present in yur cmmunity. Further, everyday actins like cvering yur cugh, staying away frm sick peple and washing yur hands ften can help prevent the spread f respiratry viruses like the flu. Vaccine Effectiveness, General Influenza viruses are cnstantly changing they can change frm ne seasn t the next r they can even change within the curse f the same seasn. This kind f gradual change is called antigenic drift. It is because f drift that the cmpsitin f the flu vaccine is reviewed annually and updated as needed t keep up with circulating viruses. Each year experts pick which viruses t include in the vaccine many mnths in advance (usually February) in rder fr vaccine t be prduced and delivered in time fr the upcming flu seasn. Because flu viruses are cnstantly changing and it takes a lng time t manufacture flu vaccine, there is always the pssibility f a sub-ptimal match between circulating viruses and the viruses in the vaccine. While a less than ptimal virus match can reduce the vaccine s effectiveness, vaccinatin can still prtect enugh t make illness milder and prevent flu-related cmplicatins. Such prtectin is pssible because antibdies created thrugh vaccinatin with ne strain f influenza viruses will ften crss-prtect against different influenza viruses.

9 Vaccine Supply Seven influenza vaccine manufacturers have prjected that as many as 151 millin t 156 millin dses f influenza vaccine will be available fr use in the United States during the influenza seasn. This prjectin is similar t that prvided by manufacturers befre influenza vaccine distributin began fr this year, with the difference being that the high end f the range is reduced by apprximately 4 millin dses. Of the verall flu vaccine supply prjected fr the seasn, manufacturers estimate that 76 millin dses will be available as quadrivalent flu vaccines. Of the ttal quadrivalent flu vaccine supply, as many as 18 millin dses f the nasal spray influenza vaccine (LAIV) have been prjected by the manufacturer t be available. During September, sme manufacturers, including thse wh develp flu vaccines apprved fr children in the United States, reprted delays in shipments that were riginally anticipated fr early fall. These early seasn shipping delays impacted certain vaccine prducts mre than thers, thus impacting sme prviders mre than thers. We understand that this can be very frustrating fr prviders and their patients wh experienced these delays. Despite these early seasn shipping delays, hwever, apprximately 85% f the ttal dses prjected fr the seasn were distributed by the end f Octber. Remaining flu vaccine dses are anticipated t be distributed during the mnth f Nvember. As f Octber 31, 2014, manufacturers reprted having shipped millin dses f flu vaccine. Sme pints t keep in mind: All nasal spray flu vaccine ffered during the seasn will be quadrivalent vaccine. Bth quadrivalent and trivalent flu shts will be available. Dn t delay getting a flu vaccine if yu want a quadrivalent vaccine and it is nt available. Mst f the flu vaccine ffered this year will be trivalent. The imprtant thing is t get vaccinated against the flu. Mre quadrivalent flu vaccine is expected t be available during future seasns.

10 Fr the latest infrmatin n flu vaccine supply, including prjectins and dses distributed, visit

CDC Influenza Division Key Points December 9, 2016

CDC Influenza Division Key Points December 9, 2016 In this dcument: Summary Key Pints Summary f Influenza Virus Labratry Data FluView Activity Update Early Influenza Vaccine Cverage Estimates fr 2016-17 Influenza Vaccine Prgram Impact Estimates fr 2015-16

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Flu Season Key Points ( )

Flu Season Key Points ( ) 2014-2015 Flu Seasn Key Pints (10-31-14) Cntents Overarching Framewrk f CDC Influenza Messaging... 3 Take 3 Messages... 3 Statements fr General Audiences... 4 Disease... 4 Vaccinatin... 6 Vaccinatin Timing...

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

Frequently asked questions: Influenza A (H1N1)v

Frequently asked questions: Influenza A (H1N1)v July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

H1N1 Influenza 09 Guidance for Residential Aged Care

H1N1 Influenza 09 Guidance for Residential Aged Care H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

Eye on Influenza. o Available Vaccine Products and Indications: See

Eye on Influenza. o Available Vaccine Products and Indications: See Archived Dcument Archive Disclaimer: The fllwing Health Care Agency dcument is fr histrical purpses nly. The infrmatin prvided was accurate at the time it was riginally presented. The Health Care Agency

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 2009: DrillSafe Update David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 Update CDC.Gv USA Pandemic H1N1 Summary Pints Virus cntinues t spread with nearly all WHO

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories:

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories: Where has Zika virus been fund? Zika Virus Prir t 2015, Zika virus utbreaks have ccurred in areas f Africa, Sutheast Asia, and the Pacific Islands. In May 2015, the Pan American Health Organizatin (PAHO)

More information

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

This information shows what new challenges are likely to require prevention efforts moving forward.

This information shows what new challenges are likely to require prevention efforts moving forward. Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP) My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made

More information

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27)

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27) MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27) The weekly West Nile Virus Surveillance Reprt utlines the mst current surveillance data and is psted weekly

More information

The research question: What was discovered in the 1940s that could treat syphilis?

The research question: What was discovered in the 1940s that could treat syphilis? Psychlgy B30 Human Sexuality Sexually Transmitted Infectins Tuskegee Syphilis Experiment Ppulatin: The research questin: What was discvered in the 1940s that culd treat syphilis? Hw many men died f syphilis

More information

Lyme Disease Surveillance in North Carolina

Lyme Disease Surveillance in North Carolina Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

Ministry of Health and Long-Term Care

Ministry of Health and Long-Term Care Ministry f Health and Lng-Term Care Infrmatin n Nvel H1N1 Influenza A - Frequently Asked Questins fr Primary Care Practitiners May 7, 2009 This infrmatin is subject t change based n evlving infrmatin n

More information

LYME DISEASE (taken from 6/20/13)

LYME DISEASE (taken from   6/20/13) LYME DISEASE (taken frm www.lymemd.rg 6/20/13) PREVENTING LYME DISEASE Understand the risks The risk f Lyme disease is year rund. Highest risk late spring t early summer. Learn t enjy the utdrs SAFELY.

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

Glaucoma Interviews: Due Tuesday, May 22 nd

Glaucoma Interviews: Due Tuesday, May 22 nd Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,

More information

Athabasca Health Authority Keewatin Yatthé Health Region Mamawetan Churchill River Health Region

Athabasca Health Authority Keewatin Yatthé Health Region Mamawetan Churchill River Health Region Athabasca Health Authrity Keewatin Yatthé Health Regin Mamawetan Churchill River Health Regin Nrthern Saskatchewan Health Indicatrs Reprt 2011 Summary Athabasca Health Authrity Keewatin Yatthé Health Regin

More information

What You Need to Know About ZIKA VIRUS

What You Need to Know About ZIKA VIRUS What Yu Need t Knw Abut ZIKA VIRUS Refugee and Immigrant Health Seminar Tuesday, Nvember 1, 2016 Malaya Fletcher, MPH Glbal Migratin & Mnitring Crdinatr PDPH Divisin f Disease Cntrl 1 Backgrund n Zika

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

Measures to Minimize Influenza Transmission at Swine Exhibitions

Measures to Minimize Influenza Transmission at Swine Exhibitions Measures t Minimize Influenza Transmissin at Swine Exhibitins It is estimated that 150 millin peple visit agricultural fairs each year in Nrth America. Agricultural exhibitins prvide valuable educatinal

More information

DRAFT Policy for the Management of Ear Wax

DRAFT Policy for the Management of Ear Wax Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

Advantage EAP Employee Assistance Program

Advantage EAP Employee Assistance Program Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse

More information

BLOOD BORNE PATHOGENS

BLOOD BORNE PATHOGENS BLOOD BORNE PATHOGENS GALVESTON ISD ANNUAL TRAINING 2018-2019 Galvestn Independent Schl District Special Prgrams/ECH Health Services Required Training Ò Training is required by the Texas Department f Health

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Reliability and Validity Plan 2017

Reliability and Validity Plan 2017 Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,

More information

Injury, Incident & Illness Procedure

Injury, Incident & Illness Procedure Injury, Incident & Illness Prcedure Injury / Incident Includes any child, adult, r emplyee injured n site. A first aid kit will be available at all times. It will be maintained in accrdance with criterin

More information

Immunisation and Disease Prevention Policy

Immunisation and Disease Prevention Policy Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Infection Control Guidelines for Cabin Crew Members on Commercial Aircraft

Infection Control Guidelines for Cabin Crew Members on Commercial Aircraft Infectin Cntrl Guidelines fr Cabin Crew Members n Cmmercial Aircraft PURPOSE These guidelines prvide cabin crew members (flight attendants) with practical measures t prtect themselves, passengers, and

More information

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps. NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting

More information

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care. Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,

More information

Little Angels Schoolhouse

Little Angels Schoolhouse Little Angels Schlhuse Sickness and Illness Plicy Aim Early Years Fundatin Stage Statutry Guidance The Prvider must prmte the gd health f the children, take necessary steps t prevent the spread f infectin

More information

Provider Information: Influenza VISs

Provider Information: Influenza VISs Prvider Infrmatin: Influenza VISs Thirteen influenza vaccine prducts are apprved fr use in the United States fr the 2014-15 influenza seasn: Name Manufacturer Age Range # f Strains Afluria bicsl 9 years

More information

UNIT 6. DEVELOPING THREAT/HAZARD-SPECIFIC ANNEXES

UNIT 6. DEVELOPING THREAT/HAZARD-SPECIFIC ANNEXES UNIT 6. DEVELOPING THREAT/HAZARD-SPECIFIC ANNEXES This page intentinally left blank. UNIT INTRODUCTION Visual 6.1 This unit presents infrmatin n annexes that shuld be included in a schl emergency peratins

More information

Key Facts about Seasonal Flu Vaccine from the Centers for Disease Control and Prevention

Key Facts about Seasonal Flu Vaccine from the Centers for Disease Control and Prevention Key Facts about Seasonal Flu Vaccine from the Centers for Disease Control and Prevention Why should people get vaccinated against the flu? Influenza is a serious disease that can lead to hospitalization

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Determining How Well a Vaccine Works -- Vaccine Match and Host Factors

Determining How Well a Vaccine Works -- Vaccine Match and Host Factors Key Pints Hw Well D Influenza (Flu) Vaccines Wrk? General There are tw types f flu vaccines: Trivalent inactivated vaccines ( flu shts ), which are given with a needle and cntain inactivated (killed) virus

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

Pediatric and adolescent preventive care and HEDIS *

Pediatric and adolescent preventive care and HEDIS * Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and

More information

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,

More information

Access to Heme Treatment in Canada - Survey 2018

Access to Heme Treatment in Canada - Survey 2018 Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,

More information

Diabetes Canada Pre-Budget Consultation Submission. Standing Committee on Finance and Economic Affairs. Government of Ontario.

Diabetes Canada Pre-Budget Consultation Submission. Standing Committee on Finance and Economic Affairs. Government of Ontario. Diabetes Canada 2018 Pre-Budget Cnsultatin Submissin Standing Cmmittee n Finance and Ecnmic Affairs Gvernment f Ontari January 17, 2018 1 Executive Summary Tday, abut 4.4 millin Ontarians, r 29 per cent

More information

CHAPTER 2. HEALTH SERVICES

CHAPTER 2. HEALTH SERVICES CHAPTER 2. HEALTH SERVICES 2.1 Treatment f substance use disrders within health services Thmas F Babr and Kerstin Stenius Overview Since the end f the Secnd Wrld War there has been a cnsistent grwth f

More information

MEDICATION GUIDE. (canagliflozin) Tablets

MEDICATION GUIDE. (canagliflozin) Tablets MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet n Lichen Planus Intrductin Lichen planus (LP) is a disease f the skin and/r mucus membranes that resembles lichen. A lichen is a cmpsite rganism that emerges

More information

Before Your Visit: Mohs Skin Cancer Surgery

Before Your Visit: Mohs Skin Cancer Surgery Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with

More information

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

FTD RESEARCH: The Value of Studies and Opportunities for Involvement FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver

More information

D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y

D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y 2 A B O U T This dcument prvides a summary f key findings fr the Derby, Derbyshire, Nttingham and

More information

MEDICATION GUIDE. (Interferon alfa-2b)

MEDICATION GUIDE. (Interferon alfa-2b) MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

HPV VACCINATION IN SANDYFORD SERVICES

HPV VACCINATION IN SANDYFORD SERVICES HPV VACCINATION IN SANDYFORD SERVICES 1. General infrmatin n HPV Vaccinatin 2. HPV vaccinatin in females 3. Yung Wmen Only 4. HPV vaccinatin in MSM 1. General infrmatin General Infrmatin fr clinicians

More information

Name: Date: Period: Notes: The Blood and Lymphatic System

Name: Date: Period: Notes: The Blood and Lymphatic System Name: Date: Perid: Cmpsitin f Bld and their Functins Red Bld Cells (aka ) Structure Ntes: The Bld and Lymphatic System D nt have a like ther cells d Cntain a specialized prtein called Hemglbin cntains

More information